150 related articles for article (PubMed ID: 29449788)
1. RRS1 gene expression involved in the progression of papillary thyroid carcinoma.
Chen F; Jin Y; Feng L; Zhang J; Tai J; Shi J; Yu Y; Lu J; Wang S; Li X; Chu P; Han S; Cheng S; Guo Y; Ni X
Cancer Cell Int; 2018; 18():20. PubMed ID: 29449788
[TBL] [Abstract][Full Text] [Related]
2. MiR-34a targets GAS1 to promote cell proliferation and inhibit apoptosis in papillary thyroid carcinoma via PI3K/Akt/Bad pathway.
Ma Y; Qin H; Cui Y
Biochem Biophys Res Commun; 2013 Nov; 441(4):958-63. PubMed ID: 24220341
[TBL] [Abstract][Full Text] [Related]
3. Regulator of Ribosome Synthesis 1 (RRS1) Stabilizes GRP78 and Promotes Breast Cancer Progression.
Sun W; Song J; Wu Q; Deng L; Zhang T; Zhang L; Hua Y; Cao Y; Hou L
Molecules; 2024 Feb; 29(5):. PubMed ID: 38474562
[TBL] [Abstract][Full Text] [Related]
4. [The difference expression and diagnostic value of RPL5 in papillary thyroid carcinoma of children and adults].
Jin YQ; Wang SC; Tai J; Zhang J; Chen F; Shi J; Yu YB; Yang YR; Ren HM; Geng D; Liu YH; Guo YL; Ni X
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2017 Nov; 52(11):830-834. PubMed ID: 29141292
[No Abstract] [Full Text] [Related]
5. RRS1 silencing suppresses colorectal cancer cell proliferation and tumorigenesis by inhibiting G2/M progression and angiogenesis.
Wu XL; Yang ZW; He L; Dong PD; Hou MX; Meng XK; Zhao HP; Wang ZY; Wang F; Baoluri ; Wurenqimuge ; Agudamu ; Jia YF; Shi L
Oncotarget; 2017 Oct; 8(47):82968-82980. PubMed ID: 29137316
[TBL] [Abstract][Full Text] [Related]
6. Effect of RRS1 gene knockdown on BT549 cell line proliferation and apoptosis in breast cancer.
Hua YN; Song JL; Ma ZL; Wu L; Zhang Z; Zhang L; Li N; Cong SB; Hou L
Neoplasma; 2019 Jan; 66(1):28-32. PubMed ID: 30509086
[TBL] [Abstract][Full Text] [Related]
7. Up-regulation of miRNA-148a inhibits proliferation, invasion, and migration while promoting apoptosis of cervical cancer cells by down-regulating RRS1.
Zhang Y; Sun B; Zhao L; Liu Z; Xu Z; Tian Y; Hao C
Biosci Rep; 2019 May; 39(5):. PubMed ID: 30910849
[TBL] [Abstract][Full Text] [Related]
8. Knockdown of RRS1 by lentiviral-mediated RNAi promotes apoptosis and suppresses proliferation of human hepatocellular carcinoma cells.
Wang J; Li Z; Zuo C; Xie Q; Li H; Jia J; Zhen Z; Qi R; Li Z; Liu D; Sun B
Oncol Rep; 2017 Oct; 38(4):2166-2172. PubMed ID: 28849112
[TBL] [Abstract][Full Text] [Related]
9. lncRNA DUXAP8 inhibits papillary thyroid carcinoma cell apoptosis via sponging the miR‑20b‑5p/SOS1 axis.
Pang R; Yang S
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33760128
[TBL] [Abstract][Full Text] [Related]
10. Knockdown of ANXA10 inhibits proliferation and promotes apoptosis of papillary thyroid carcinoma cells by down-regulating TSG101 thereby inactivating the MAPK/ERK signaling pathway.
Wei T; Zhu X
J Bioenerg Biomembr; 2021 Aug; 53(4):429-440. PubMed ID: 34032966
[TBL] [Abstract][Full Text] [Related]
11. miR-183 regulates biological behavior in papillary thyroid carcinoma by targeting the programmed cell death 4.
Wei C; Song H; Sun X; Li D; Song J; Hua K; Fang L
Oncol Rep; 2015 Jul; 34(1):211-20. PubMed ID: 26063221
[TBL] [Abstract][Full Text] [Related]
12. Circ_PSD3 promotes the progression of papillary thyroid carcinoma via the miR-637/HEMGN axis.
Li Z; Huang X; Liu A; Xu J; Lai J; Guan H; Ma J
Life Sci; 2021 Jan; 264():118622. PubMed ID: 33203523
[TBL] [Abstract][Full Text] [Related]
13. RRS1 Promotes Retinoblastoma Cell Proliferation and Invasion via Activating the AKT/mTOR Signaling Pathway.
Yan X; Wu S; Liu Q; Zhang J
Biomed Res Int; 2020; 2020():2420437. PubMed ID: 33204686
[TBL] [Abstract][Full Text] [Related]
14. Oncogenic pseudogene DUXAP10 knockdown suppresses proliferation and invasion and induces apoptosis of papillary thyroid carcinoma cells by inhibition of Akt/mTOR pathway.
Li J; Jiang L; Liu Z; Li Y; Xu Y; Liu H
Clin Exp Pharmacol Physiol; 2020 Aug; 47(8):1473-1483. PubMed ID: 32215944
[TBL] [Abstract][Full Text] [Related]
15. LncRNA SNHG12 promotes the proliferation and metastasis of papillary thyroid carcinoma cells through regulating wnt/β-catenin signaling pathway.
Ding S; Qu W; Jiao Y; Zhang J; Zhang C; Dang S
Cancer Biomark; 2018; 22(2):217-226. PubMed ID: 29630517
[TBL] [Abstract][Full Text] [Related]
16. Tumor promoting effects of glucagon receptor: a promising biomarker of papillary thyroid carcinoma via regulating EMT and P38/ERK pathways.
Jiang HC; Chen XR; Sun HF; Nie YW
Hum Cell; 2020 Jan; 33(1):175-184. PubMed ID: 31782107
[TBL] [Abstract][Full Text] [Related]
17. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract][Full Text] [Related]
18. Functional role of RRS1 in breast cancer cell proliferation.
Song J; Ma Z; Hua Y; Xu J; Li N; Ju C; Hou L
J Cell Mol Med; 2018 Dec; 22(12):6304-6313. PubMed ID: 30320499
[TBL] [Abstract][Full Text] [Related]
19. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
Zhou SL; Tang QL; Zhou SX; Ren RZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
[TBL] [Abstract][Full Text] [Related]
20. Silencing long non-coding RNAs nicotinamide nucleotide transhydrogenase antisense RNA 1 inhibited papillary thyroid cancer cell proliferation, migration and invasion and promoted apoptosis via targeting miR-199a-5p.
Wang D; Zheng Y
Endocr J; 2021 May; 68(5):583-597. PubMed ID: 33612561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]